Brief: Aap Implantate Q1 EBITDA Loss Of EUR 0.2 Mln

aap Implantate AG

28/05/2021 06:35

May 28 (Reuters) - Aap Implantate AG  AAQ1k.DE :
    * DGAP-NEWS: Q1/21: SUCCESSFUL START TO THE YEAR WITH SALES
GROWTH
(+9%) AND SIGNIFICANT EARNINGS IMPROVEMENT (+91%) DESPITE STILL
BURDENING COVID-19 PANDEMIC - RESTRUCTURING SUCCESSES CLEARLY
VISIBLE
    * Q1 EBITDA LOSS -200,000 EUR VERSUS -2.2 MILLION EUR LOSS
YEAR
AGO
    * Q1 SALES INCREASED BY 9% YEAR-ON-YEAR TO EUR 2.7 MILLION
(Q1/2020: EUR 2.5 MILLION)
    * EBITDA OF EUR -0.2 MILLION IN Q1 OF 2021 COMPARED TO
CORRESPONDING PERIOD OF PREVIOUS YEAR (Q1/2020: EUR -2.2
MILLION)
    * EXCLUDING ONE-TIME EFFECTS, Q1 RECURRING EBITDA ALSO
IMPROVED
SUBSTANTIALLY YEAR-ON-YEAR TO EUR -0.2 MILLION (Q1/2020: EUR
-1.4 MILLION)
    * AAP EXPECTS SALES GROWTH FOR Q2 OF 2021 AND PLANS A SALES
LEVEL
ABOVE EUR 3 MILLION MARK (Q2/2020: EUR 1.9 MILLION, H1/2020: EUR
4.4 MILLION)

Source text for Eikon:  ID:nEQ5P0hQQa 
Further company coverage:  AAQ1k.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))